Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 ...

Microsoft has backed out of building data centers, Intel's factory opening has been delayed to 2030, but one tech industry is going strong in central Ohio: Biotechnology. The now multibillion dollar ...

Rigel Pharmaceuticals has landed on CNBC's list of top performing stocks of companies located in San Francisco.

A well-crafted narrative helps investors see not just the molecule in front of them, but the broader therapeutic and ...

Biotechnology is the application of biological organisms, cells, or molecules to produce a product or service for the betterment of humankind. This area of study includes aspects of molecular biology, ...

XBI is a biotech-focused ETF offering equal-weight exposure to U.S. biotechnology companies. The SPDR S&P Biotech ETF tracks the performance of the S&P Biotechnology Select Industry Index. XBI ...

The bar for product differentiation and commercial viability has never been higher. Efficiency, external collaboration, and ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy. A full transcript is below. This ...

For decades, women’s health has struggled with gaps in research and a lack of tools designed specifically for female biology. Hormone testing, in particular, has often left women with raw numbers and ...